—Surgical ventricular septal reduction or alcohol septal ablation therapy? A study in France tapped a nationwide database to better describe and compare the safety of the 2 septal reduction therapy ...
For people with obstructive hypertrophic cardiomyopathy (HCM) whose symptoms don’t improve with medication, surgical options like septal myectomy or alcohol septal ablation can be life-changing.
A 42-year-old woman with obstructive hypertrophic cardiomyopathy (HCM) was referred for alcohol septal ablation (ASA). She had been diagnosed with HCM 20 years earlier following presentation with ...
The occurrence of high-grade conduction disturbances after alcohol septal ablation (ASA) did not translate into worse long-term survival for people with obstructive hypertrophic cardiomyopathy (HCM), ...
Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...
Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...
Hypertrophic cardiomyopathy is an inherited condition that affects up to 750,000 people in the United States. It often involves left ventricular outflow tract obstruction. Septal reduction therapies ...
Everyday Health on MSN
Is it time to change your obstructive hypertrophic cardiomyopathy treatment? 8 questions to ask your cardiologist
If your oHCM symptoms are returning or your energy is flagging, your treatment plan may need an update. Here's how to talk to ...
A University of Texas at Arlington multidisciplinary team will use a National Institutes of Health (NIH) grant to research new ways to improve the safety and effectiveness of medical procedures on ...
Please provide your email address to receive an email when new articles are posted on . Hypertrophic cardiomyopathy is the most common monogenic CV disorder, yet perhaps the most frequently ...
Credit: Getty Images HCM is a genetic disease, usually caused by mutations in sarcomere proteins such as myosin, actin, tropomyosin, and myosin-binding protein C. Hypertrophic cardiomyopathy (HCM) ...
HANGZHOU, China, March 4, 2023 /PRNewswire/ -- On March 3, Venus Medtech (Hangzhou) Inc. (Venus Medtech, 2500.HK), trailblazer in structural heart therapies worldwide, announced that the Liwen RF™ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results